/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,.
Anixa Biosciences, Inc. announced that it has established a Cancer Business Advisory Board, whose purpose is to provide guidance on the Company s clinical and business development initiatives. The.
Innovations in clinical trial design and a shift to classifying cancers based on their molecular and mutational profiles offers a hopeful path forward.
/PRNewswire/ Today, the National Comprehensive Cancer Network® (NCCN®) an alliance of leading cancer centers presented new recommendations for screening and.